Literature DB >> 22763381

Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.

Yael Laitman1, Bing-Jian Feng, Itay M Zamir, Jeffrey N Weitzel, Paul Duncan, Danielle Port, Eswary Thirthagiri, Soo-Hwang Teo, Gareth Evans, Ayse Latif, William G Newman, Ruth Gershoni-Baruch, Jamal Zidan, Shani Shimon-Paluch, David Goldgar, Eitan Friedman.   

Abstract

The 185delAG* BRCA1 mutation is encountered primarily in Jewish Ashkenazi and Iraqi individuals, and sporadically in non-Jews. Previous studies estimated that this is a founder mutation in Jewish mutation carriers that arose before the dispersion of Jews in the Diaspora ~2500 years ago. The aim of this study was to assess the haplotype in ethnically diverse 185delAG* BRCA1 mutation carriers, and to estimate the age at which the mutation arose. Ethnically diverse Jewish and non-Jewish 185delAG*BRCA1 mutation carriers and their relatives were genotyped using 15 microsatellite markers and three SNPs spanning 12.5 MB, encompassing the BRCA1 gene locus. Estimation of mutation age was based on a subset of 11 markers spanning a region of ~5 MB, using a previously developed algorithm applying the maximum likelihood method. Overall, 188 participants (154 carriers and 34 noncarriers) from 115 families were included: Ashkenazi, Iraq, Kuchin-Indians, Syria, Turkey, Iran, Tunisia, Bulgaria, non-Jewish English, non-Jewish Malaysian, and Hispanics. Haplotype analysis indicated that the 185delAG mutation arose 750-1500 years ago. In Ashkenazim, it is a founder mutation that arose 61 generations ago, and with a small group of founder mutations was introduced into the Hispanic population (conversos) ~650 years ago, and into the Iraqi-Jewish community ~450 years ago. The 185delAG mutation in the non-Jewish populations in Malaysia and the UK arose at least twice independently. We conclude that the 185delAG* BRCA1 mutation resides on a common haplotype among Ashkenazi Jews, and arose about 61 generations ago and arose independently at least twice in non-Jews.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22763381      PMCID: PMC3548269          DOI: 10.1038/ejhg.2012.124

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  38 in total

1.  Estimate of the mutation rate per nucleotide in humans.

Authors:  M W Nachman; S L Crowell
Journal:  Genetics       Date:  2000-09       Impact factor: 4.562

2.  Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins.

Authors:  N Ah Mew; N Hamel; M Galvez; M Al-Saffar; W D Foulkes
Journal:  Clin Genet       Date:  2002-08       Impact factor: 4.438

3.  Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

Authors:  S L Neuhausen; A K Godwin; R Gershoni-Baruch; E Schubert; J Garber; D Stoppa-Lyonnet; E Olah; B Csokay; O Serova; F Lalloo; A Osorio; M Stratton; K Offit; J Boyd; M A Caligo; R J Scott; A Schofield; E Teugels; M Schwab; L Cannon-Albright; T Bishop; D Easton; J Benitez; M C King; B A Ponder; B Weber; P Devilee; A Borg; S A Narod; D Goldgar
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

4.  Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection.

Authors:  Safinaz S Ibrahim; Elsayed E Hafez; Mervat M Hashishe
Journal:  J Exp Clin Cancer Res       Date:  2010-06-25

5.  Mutation of human short tandem repeats.

Authors:  J L Weber; C Wong
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

6.  Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.

Authors:  S Cierniková; M Tomka; M Kovác; V Stevurková; V Zajac
Journal:  Neoplasma       Date:  2006       Impact factor: 2.575

7.  The impact of Converso Jews on the genomes of modern Latin Americans.

Authors:  C Velez; P F Palamara; J Guevara-Aguirre; L Hao; T Karafet; M Guevara-Aguirre; A Pearlman; C Oddoux; M Hammer; E Burns; I Pe'er; G Atzmon; H Ostrer
Journal:  Hum Genet       Date:  2011-07-26       Impact factor: 4.132

8.  Breast cancer predisposing alleles in Poland.

Authors:  B Górski; C Cybulski; T Huzarski; T Byrski; J Gronwald; A Jakubowska; M Stawicka; S Gozdecka-Grodecka; M Szwiec; K Urbański; J Mituś; E Marczyk; J Dziuba; P Wandzel; D Surdyka; O Haus; H Janiszewska; T Debniak; A Tołoczko-Grabarek; K Medrek; B Masojć; M Mierzejewski; E Kowalska; S A Narod; J Lubiński
Journal:  Breast Cancer Res Treat       Date:  2005-07       Impact factor: 4.872

9.  Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population.

Authors:  O Díez; M Doménech; M C Alonso; J Brunet; J Sanz; J Cortés; E del Río; M Baiget
Journal:  Hum Genet       Date:  1998-12       Impact factor: 4.132

10.  Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.

Authors:  D Gareth Evans; Andrew Shenton; Emma Woodward; Fiona Lalloo; Anthony Howell; Eamonn R Maher
Journal:  BMC Cancer       Date:  2008-05-30       Impact factor: 4.430

View more
  18 in total

1.  Genetic diversity of disease-associated loci in Turkish population.

Authors:  Sefayet Karaca; Tomris Cesuroglu; Mehmet Karaca; Sema Erge; Renato Polimanti
Journal:  J Hum Genet       Date:  2015-02-26       Impact factor: 3.172

Review 2.  Mutations in context: implications of BRCA testing in diverse populations.

Authors:  Gabriela E S Felix; Yonglan Zheng; Olufunmilayo I Olopade
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

3.  Genomic Disparities in Breast Cancer Among Latinas.

Authors:  Filipa Lynce; Kristi D Graves; Lina Jandorf; Charite Ricker; Eida Castro; Laura Moreno; Bianca Augusto; Laura Fejerman; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

4.  Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India.

Authors:  Taruna Rajagopal; Arun Seshachalam; Arunachalam Jothi; Krishna Kumar Rathnam; Srikanth Talluri; Sivaramakrishnan Venkatabalasubranian; Nageswara Rao Dunna
Journal:  Mol Biol Rep       Date:  2022-01-12       Impact factor: 2.316

5.  Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine.

Authors:  Anastasiia Samusieva; Svitlana Serga; Sergiy Klymenko; Lyudmila Rybchenko; Bohdana Klimuk; Liubov Zakhartseva; Natalia Gorovenko; Olga Lobanova; Zoia Rossokha; Liliia Fishchuk; Nataliia Levkovich; Nataliia Medvedieva; Olena Popova; Valeriy Cheshuk; Mariia Inomistova; Natalia Khranovska; Oksana Skachkova; Yurii Michailovich; Olga Ponomarova; Iryna Kozeretska
Journal:  Breast Cancer Res Treat       Date:  2022-08-05       Impact factor: 4.624

6.  Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing.

Authors:  Chloé Tessereau; Yann Lesecque; Nastasia Monnet; Monique Buisson; Laure Barjhoux; Mélanie Léoné; Bingjian Feng; David E Goldgar; Olga M Sinilnikova; Sylvain Mousset; Laurent Duret; Sylvie Mazoyer
Journal:  Nucleic Acids Res       Date:  2014-07-17       Impact factor: 16.971

7.  Age at diagnosis of cancer in 185delAG BRCA1 mutation carriers of diverse ethnicities: tentative evidence for modifier factors.

Authors:  Yael Laitman; Rachel Michaelson-Cohen; Rakefet Chen-Shtoyerman; Yael Goldberg; Orit Reish; Rinat Bernstein-Molho; Ephrat Levy-Lahad; Noa Ephrat Ben Baruch; Inbal Kedar; D Gareth Evans; Sara Haim; Shani Paluch-Shimon; Eitan Friedman
Journal:  Fam Cancer       Date:  2020-11-09       Impact factor: 2.375

8.  BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.

Authors:  Tara M Friebel; Irene L Andrulis; Judith Balmaña; Amie M Blanco; Fergus J Couch; Mary B Daly; Susan M Domchek; Douglas F Easton; William D Foulkes; Patricia A Ganz; Judy Garber; Gord Glendon; Mark H Greene; Peter J Hulick; Claudine Isaacs; Rachel C Jankowitz; Beth Y Karlan; Judy Kirk; Ava Kwong; Annette Lee; Fabienne Lesueur; Karen H Lu; Katherine L Nathanson; Susan L Neuhausen; Kenneth Offit; Edenir I Palmero; Priyanka Sharma; Marc Tischkowitz; Amanda E Toland; Nadine Tung; Elizabeth J van Rensburg; Ana Vega; Jeffrey N Weitzel; Gemo Study Collaborators; Kent F Hoskins; Tara Maga; Michael T Parsons; Lesley McGuffog; Antonis C Antoniou; Georgia Chenevix-Trench; Dezheng Huo; Olufunmilayo I Olopade; Timothy R Rebbeck
Journal:  Hum Mutat       Date:  2019-07-03       Impact factor: 4.700

9.  VariantSpark: population scale clustering of genotype information.

Authors:  Aidan R O'Brien; Neil F W Saunders; Yi Guo; Fabian A Buske; Rodney J Scott; Denis C Bauer
Journal:  BMC Genomics       Date:  2015-12-10       Impact factor: 3.969

10.  Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

Authors:  Timothy R Rebbeck; Tara M Friebel; Eitan Friedman; Ute Hamann; Dezheng Huo; Ava Kwong; Edith Olah; Olufunmilayo I Olopade; Angela R Solano; Soo-Hwang Teo; Mads Thomassen; Jeffrey N Weitzel; T L Chan; Fergus J Couch; David E Goldgar; Torben A Kruse; Edenir Inêz Palmero; Sue Kyung Park; Diana Torres; Elizabeth J van Rensburg; Lesley McGuffog; Michael T Parsons; Goska Leslie; Cora M Aalfs; Julio Abugattas; Julian Adlard; Simona Agata; Kristiina Aittomäki; Lesley Andrews; Irene L Andrulis; Adalgeir Arason; Norbert Arnold; Banu K Arun; Ella Asseryanis; Leo Auerbach; Jacopo Azzollini; Judith Balmaña; Monica Barile; Rosa B Barkardottir; Daniel Barrowdale; Javier Benitez; Andreas Berger; Raanan Berger; Amie M Blanco; Kathleen R Blazer; Marinus J Blok; Valérie Bonadona; Bernardo Bonanni; Angela R Bradbury; Carole Brewer; Bruno Buecher; Saundra S Buys; Trinidad Caldes; Almuth Caliebe; Maria A Caligo; Ian Campbell; Sandrine M Caputo; Jocelyne Chiquette; Wendy K Chung; Kathleen B M Claes; J Margriet Collée; Jackie Cook; Rosemarie Davidson; Miguel de la Hoya; Kim De Leeneer; Antoine de Pauw; Capucine Delnatte; Orland Diez; Yuan Chun Ding; Nina Ditsch; Susan M Domchek; Cecilia M Dorfling; Carolina Velazquez; Bernd Dworniczak; Jacqueline Eason; Douglas F Easton; Ros Eeles; Hans Ehrencrona; Bent Ejlertsen; Christoph Engel; Stefanie Engert; D Gareth Evans; Laurence Faivre; Lidia Feliubadaló; Sandra Fert Ferrer; Lenka Foretova; Jeffrey Fowler; Debra Frost; Henrique C R Galvão; Patricia A Ganz; Judy Garber; Marion Gauthier-Villars; Andrea Gehrig; Anne-Marie Gerdes; Paul Gesta; Giuseppe Giannini; Sophie Giraud; Gord Glendon; Andrew K Godwin; Mark H Greene; Jacek Gronwald; Angelica Gutierrez-Barrera; Eric Hahnen; Jan Hauke; Alex Henderson; Julia Hentschel; Frans B L Hogervorst; Ellen Honisch; Evgeny N Imyanitov; Claudine Isaacs; Louise Izatt; Angel Izquierdo; Anna Jakubowska; Paul James; Ramunas Janavicius; Uffe Birk Jensen; Esther M John; Joseph Vijai; Katarzyna Kaczmarek; Beth Y Karlan; Karin Kast; KConFab Investigators; Sung-Won Kim; Irene Konstantopoulou; Jacob Korach; Yael Laitman; Adriana Lasa; Christine Lasset; Conxi Lázaro; Annette Lee; Min Hyuk Lee; Jenny Lester; Fabienne Lesueur; Annelie Liljegren; Noralane M Lindor; Michel Longy; Jennifer T Loud; Karen H Lu; Jan Lubinski; Eva Machackova; Siranoush Manoukian; Véronique Mari; Cristina Martínez-Bouzas; Zoltan Matrai; Noura Mebirouk; Hanne E J Meijers-Heijboer; Alfons Meindl; Arjen R Mensenkamp; Ugnius Mickys; Austin Miller; Marco Montagna; Kirsten B Moysich; Anna Marie Mulligan; Jacob Musinsky; Susan L Neuhausen; Heli Nevanlinna; Joanne Ngeow; Huu Phuc Nguyen; Dieter Niederacher; Henriette Roed Nielsen; Finn Cilius Nielsen; Robert L Nussbaum; Kenneth Offit; Anna Öfverholm; Kai-Ren Ong; Ana Osorio; Laura Papi; Janos Papp; Barbara Pasini; Inge Sokilde Pedersen; Ana Peixoto; Nina Peruga; Paolo Peterlongo; Esther Pohl; Nisha Pradhan; Karolina Prajzendanc; Fabienne Prieur; Pascal Pujol; Paolo Radice; Susan J Ramus; Johanna Rantala; Muhammad Usman Rashid; Kerstin Rhiem; Mark Robson; Gustavo C Rodriguez; Mark T Rogers; Vilius Rudaitis; Ane Y Schmidt; Rita Katharina Schmutzler; Leigha Senter; Payal D Shah; Priyanka Sharma; Lucy E Side; Jacques Simard; Christian F Singer; Anne-Bine Skytte; Thomas P Slavin; Katie Snape; Hagay Sobol; Melissa Southey; Linda Steele; Doris Steinemann; Grzegorz Sukiennicki; Christian Sutter; Csilla I Szabo; Yen Y Tan; Manuel R Teixeira; Mary Beth Terry; Alex Teulé; Abigail Thomas; Darcy L Thull; Marc Tischkowitz; Silvia Tognazzo; Amanda Ewart Toland; Sabine Topka; Alison H Trainer; Nadine Tung; Christi J van Asperen; Annemieke H van der Hout; Lizet E van der Kolk; Rob B van der Luijt; Mattias Van Heetvelde; Liliana Varesco; Raymonda Varon-Mateeva; Ana Vega; Cynthia Villarreal-Garza; Anna von Wachenfeldt; Lisa Walker; Shan Wang-Gohrke; Barbara Wappenschmidt; Bernhard H F Weber; Drakoulis Yannoukakos; Sook-Yee Yoon; Cristina Zanzottera; Jamal Zidan; Kristin K Zorn; Christina G Hutten Selkirk; Peter J Hulick; Georgia Chenevix-Trench; Amanda B Spurdle; Antonis C Antoniou; Katherine L Nathanson
Journal:  Hum Mutat       Date:  2018-03-12       Impact factor: 4.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.